File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Measurement of multiple oxidized lipid products from a single plasma sample from healthy volunteers and clinical patients

TitleMeasurement of multiple oxidized lipid products from a single plasma sample from healthy volunteers and clinical patients
Authors
Issue Date2008
PublisherGordon and Breach.
Citation
The 2008 Meeting of the Society for Free Radical Research Europe (SFRR-E), Berlin, Germany, 5-9 July 2008. In Free Radical Research, 2008, v. 42 n. S1, p. S107 How to Cite?
AbstractMany oxidized lipid products have been associated with diseases such as atherosclerosis, stroke, thalassemia and diabetes mellitus. These products include F2-isoprostanes (F2-IsoPs), hydroxyeicosatetraenoic acid products (HETEs) and oxysterols or cholesterol oxidation products (COPs). Each product is often measured individually in separate blood samples. Here we present a method capable of measuring F2-IsoPs, HETEs, COPs and arachidonate using a single plasma or serum sample. As examples for the application of the method, clinical patient data from stroke, dengue and diabetic mellitus patients are presented. A volume of plasma or serum sample (1 ml) is spiked with heavy isotopic standards and hydrolysed in alkali with organic solvent. It is then purified using anionic exchange solid phase extraction (SPE). After washing the SPE column, hexane and hexane/ethyl acetate portions are collected and combined for COPs measurement. Afterwards, the column is loaded with hexane/ethanol/acetic acid and fractions collected for total F2-IsoPs, total HETEs and arachidonate measurement. All compounds in the eluates are measured by gas chromatography-mass spectrometry. The robustness of the method was tested by the efficiency of SPE and reproducibility for all compounds measured. The method showed high and reliable efficiency of SPE and reproducibility of oxidized lipid products and were measurable in plasma of healthy volunteers and clinical patients. For example, levels of total F2- IsoPs 0.4590.26 ng/ml (n 157), total HETEs 34.1916.4 ng/ml (n 21) total arachidonate 68.4924.5 ug/ml (n 33), and COPs 7- ketocholesterol 12.396.6 ng/ml, 7b-hydroxycholesterol 6.393.5 ng/ ml, 7a-hydroxycholesterol 15.197.1 ng/ml, 24-hydroxycholesterol 41.4918.2 ng/ml and 27-hydroxycholesterol 29.1916.8ng/ml (n 26) were recorded in healthy volunteers. The method was also applicable in stroke patients where total F2-IsoPs 0.9890.38 ng/ml (n 21), total HETEs 33.9922.1 ng/ml (n 15), total arachidonate 90.4930.7 ug/ml (n 21), and COPs 7-ketocholesterol 27.9917.6 ng/ml, 7b-hydroxycholesterol 31.5918.9 ng/ml, 7a-hydroxycholesterol 5.591.6 ng/ml, 24-hydroxycholesterol 124.69102.4 ng/ml and 27- hydroxycholesterol 37.6919.0 ng/ml (n 21) were recorded. Our investigation presented indicates that the method developed is applicable for the measurement of lipid oxidation products in human clinical settings or in small animals where plasma samples are limited.
Persistent Identifierhttp://hdl.handle.net/10722/181630
ISSN
2015 Impact Factor: 2.949
2015 SCImago Journal Rankings: 1.159

 

DC FieldValueLanguage
dc.contributor.authorLee, JCY-
dc.contributor.authorHuang, SH-
dc.contributor.authorJenner, AM-
dc.contributor.authorSeet, RCS-
dc.contributor.authorHalliwell, B-
dc.date.accessioned2013-03-18T04:26:03Z-
dc.date.available2013-03-18T04:26:03Z-
dc.date.issued2008-
dc.identifier.citationThe 2008 Meeting of the Society for Free Radical Research Europe (SFRR-E), Berlin, Germany, 5-9 July 2008. In Free Radical Research, 2008, v. 42 n. S1, p. S107-
dc.identifier.issn1071-5762-
dc.identifier.urihttp://hdl.handle.net/10722/181630-
dc.description.abstractMany oxidized lipid products have been associated with diseases such as atherosclerosis, stroke, thalassemia and diabetes mellitus. These products include F2-isoprostanes (F2-IsoPs), hydroxyeicosatetraenoic acid products (HETEs) and oxysterols or cholesterol oxidation products (COPs). Each product is often measured individually in separate blood samples. Here we present a method capable of measuring F2-IsoPs, HETEs, COPs and arachidonate using a single plasma or serum sample. As examples for the application of the method, clinical patient data from stroke, dengue and diabetic mellitus patients are presented. A volume of plasma or serum sample (1 ml) is spiked with heavy isotopic standards and hydrolysed in alkali with organic solvent. It is then purified using anionic exchange solid phase extraction (SPE). After washing the SPE column, hexane and hexane/ethyl acetate portions are collected and combined for COPs measurement. Afterwards, the column is loaded with hexane/ethanol/acetic acid and fractions collected for total F2-IsoPs, total HETEs and arachidonate measurement. All compounds in the eluates are measured by gas chromatography-mass spectrometry. The robustness of the method was tested by the efficiency of SPE and reproducibility for all compounds measured. The method showed high and reliable efficiency of SPE and reproducibility of oxidized lipid products and were measurable in plasma of healthy volunteers and clinical patients. For example, levels of total F2- IsoPs 0.4590.26 ng/ml (n 157), total HETEs 34.1916.4 ng/ml (n 21) total arachidonate 68.4924.5 ug/ml (n 33), and COPs 7- ketocholesterol 12.396.6 ng/ml, 7b-hydroxycholesterol 6.393.5 ng/ ml, 7a-hydroxycholesterol 15.197.1 ng/ml, 24-hydroxycholesterol 41.4918.2 ng/ml and 27-hydroxycholesterol 29.1916.8ng/ml (n 26) were recorded in healthy volunteers. The method was also applicable in stroke patients where total F2-IsoPs 0.9890.38 ng/ml (n 21), total HETEs 33.9922.1 ng/ml (n 15), total arachidonate 90.4930.7 ug/ml (n 21), and COPs 7-ketocholesterol 27.9917.6 ng/ml, 7b-hydroxycholesterol 31.5918.9 ng/ml, 7a-hydroxycholesterol 5.591.6 ng/ml, 24-hydroxycholesterol 124.69102.4 ng/ml and 27- hydroxycholesterol 37.6919.0 ng/ml (n 21) were recorded. Our investigation presented indicates that the method developed is applicable for the measurement of lipid oxidation products in human clinical settings or in small animals where plasma samples are limited.-
dc.languageeng-
dc.publisherGordon and Breach.-
dc.relation.ispartofFree Radical Research-
dc.titleMeasurement of multiple oxidized lipid products from a single plasma sample from healthy volunteers and clinical patientsen_US
dc.typeConference_Paperen_US
dc.identifier.emailLee, JCY: jettylee@hku.hk-
dc.description.natureabstract-
dc.identifier.doi10.1080/10715760802207914-
dc.identifier.volume42-
dc.identifier.issueS1-
dc.identifier.spageS107-
dc.identifier.epageS107-
dc.publisher.placeLondon-
dc.description.otherThe 2008 Meeting of the Society for Free Radical Research Europe (SFRR-E), Berlin, Germany, 5-9 July 2008. In Free Radical Research, 2008, v. 42 n. S1, p. S107-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats